Fidelity European Trust (LON:FEV) Shares Break Above 200 Day Moving Average – Here’s What Happened

Fidelity European Trust (LON:FEV)’s stock price passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of GBX 418.94 and traded as high as GBX 420. Fidelity European Trust shares last traded at GBX 419.50, with a volume of 3,688,363 shares.

Fidelity European Trust Stock Up 0.8%

The company has a debt-to-equity ratio of 1.34, a quick ratio of 5.81 and a current ratio of 7.70. The firm has a market capitalization of £2.04 billion, a PE ratio of 8.21 and a beta of 1.16. The company has a fifty day moving average price of GBX 418.46 and a 200-day moving average price of GBX 418.90.

Fidelity European Trust (LON:FEV) last posted its earnings results on Tuesday, September 8th. The company reported GBX 9.17 earnings per share for the quarter. Fidelity European Trust had a net margin of 91.36% and a return on equity of 11.35%. As a group, analysts expect that Fidelity European Trust will post 62.99 earnings per share for the current year.

Insider Buying and Selling

In other Fidelity European Trust news, insider Ivan Rogers acquired 1,400 shares of the company’s stock in a transaction on Tuesday, November 3rd. The stock was acquired at an average cost of GBX 414 per share, with a total value of £5,796. 0.09% of the stock is owned by company insiders.

Fidelity European Trust Company Profile

Fidelity European Trust PLC aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles. The Trust invests predominantly in continental European equities (and their related securities) and up to 20% of gross assets may be invested in companies outside of the continent. It follows a consistent bottom-up approach, seeking to identify companies able to grow dividends over a three to five-year horizon. Viewed as a whole, the European Union is the world’s second largest economy and home to some of the strongest, most stable and resilient companies.